Find the latest Avenue Therapeutics, Inc. ATXI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Explore Avenue Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATXI. Avenue Therapeutics shares are trading lower by 20.7% during Monday's ...

Short interest in Avenue Therapeutics Inc (NASDAQ:ATXI) increased during the last reporting period, rising from 80.55K to 154.92K. This put 7.54% of the company's publicly available shares short.

In a challenging year for Avenue Therapeutics (NASDAQ:ATXI) Inc., the pharmaceutical company's stock has reached a 52-week low, trading at $2.17. This price point marks a ...

AVENUE THERAPEUTICS ($ATXI) is expected to release its quarterly earnings data on Monday, March 17th after market close, per Finnhub. Analysts are expecting revenue ...

The Ameren Transmission segment consists of the aggregated electric transmission businesses of Ameren Illinois and Ameren Transmission Company of Illinois (ATXI). The company was founded in 1902 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Topline data in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy anticipated around year-end 2024MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ...